Chronic systemic inflammation, aging, and obesity have been reported to downregulate FFAR4 expression in osteoclasts and osteoblasts, which may impair the anti-inflammatory and bone-protective actions of DHA in such conditions [62,63]. The gene discussed is FFAR4; the disease is obesity due to melanocortin 4 receptor deficiency.